Chiesi USA, Inc.
3
Recalls
0
Units Recalled
0
Injuries
0
Deaths
Categories: Drug
2026-04-01 to 2026-09-09
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-09-09 | FDA Drug | FDA Recall: Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intr | Chiesi USA, Inc. | Class III | N/A |
| 2026-07-22 | FDA Drug | FDA Recall: CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, | Chiesi USA, Inc. | Class II | N/A |
| 2026-04-01 | FDA Drug | FDA Recall: CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi US | Chiesi USA, Inc. | Class II | N/A |